President Donald Trump and senior government officials' communication around the emergency use authorization for convalescent plasma for COVID-19 is sowing new doubts that the US Food and Drug Administration will make a science-based decision on if, and when, to grant clearance to any COVID-19 vaccines.
The damage from the plasma rollout – where FDA Commissioner Stephen Hahn and Health and Human Services Secretary Alex Azar...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?